Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Glucotrack (GCTK) Shares Outstanding (Diluted Average) (2016 - 2019)

Glucotrack's Shares Outstanding (Diluted Average) history spans 6 years, with the latest figure at $162.0 million for Q3 2019.

  • For the quarter ending Q3 2019, Shares Outstanding (Diluted Average) rose 1991.76% year-over-year to $162.0 million, compared with a TTM value of $162.0 million through Sep 2019, up 1991.76%, and an annual FY2018 reading of $8.4 million, up 33.59% over the prior year.
  • Shares Outstanding (Diluted Average) for Q3 2019 was $162.0 million at Glucotrack, up from $149.8 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $162.0 million in Q3 2019, with the low at $5.4 million in Q2 2015.
  • Average Shares Outstanding (Diluted Average) over 5 years is $27.7 million, with a median of $6.2 million recorded in 2017.
  • Year-over-year, Shares Outstanding (Diluted Average) rose 1.97% in 2015 and then surged 1991.76% in 2019.
  • Tracing GCTK's Shares Outstanding (Diluted Average) over 5 years: stood at $5.5 million in 2015, then rose by 5.7% to $5.8 million in 2016, then grew by 8.58% to $6.3 million in 2017, then surged by 33.59% to $8.4 million in 2018, then soared by 1829.45% to $162.0 million in 2019.
  • Per Business Quant, the three most recent readings for GCTK's Shares Outstanding (Diluted Average) are $162.0 million (Q3 2019), $149.8 million (Q2 2019), and $8.4 million (Q4 2018).